300 related articles for article (PubMed ID: 32531536)
1. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
Mohamed-Hussein AAR; Aly KME; Ibrahim MAA
Med Hypotheses; 2020 Nov; 144():109975. PubMed ID: 32531536
[No Abstract] [Full Text] [Related]
2. Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?
Macciò A; Madeddu C; Caocci G; La Nasa G
J Thromb Haemost; 2020 Nov; 18(11):3106-3108. PubMed ID: 32692894
[No Abstract] [Full Text] [Related]
3. Warfarin versus aspirin for stroke prevention (BAFTA).
Diug B; Lowthian J; Evans S
Lancet; 2007 Nov; 370(9599):1606; author reply 1606-7. PubMed ID: 17993355
[No Abstract] [Full Text] [Related]
4. Stroke prevention in elderly patients with atrial fibrillation.
Garcia D; Hylek E
Lancet; 2007 Aug; 370(9586):460-1. PubMed ID: 17693158
[No Abstract] [Full Text] [Related]
5. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
[No Abstract] [Full Text] [Related]
6. Estimating the impact of COVID-19-induced coagulopathy.
Subramaniam A; Alamgeer M
Ann Acad Med Singap; 2021 Apr; 50(4):294-296. PubMed ID: 33990816
[No Abstract] [Full Text] [Related]
7. Minimizing bleeding events.
Agewall S
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):271-272. PubMed ID: 32932523
[No Abstract] [Full Text] [Related]
8. A proposal for the management of COVID-19-induced coagulopathy in adults.
Ignacio-Ibarra G; García-Lee MT; González-Ávila AI; García-Chávez J; Guzmán-Chores L; Cruz CL; Lugo-García Y; Juárez-Lara J; García-Vázquez M; Madera-Maldonado CE; Ramos-Peñafiel CO; Majluf-Cruz A
Gac Med Mex; 2021; 157(2):201-206. PubMed ID: 34270538
[TBL] [Abstract][Full Text] [Related]
9. The ten most commonly asked questions about stroke prevention in atrial fibrillation.
Halperin JL
Cardiol Rev; 2001; 9(4):187-92. PubMed ID: 11464805
[No Abstract] [Full Text] [Related]
10. COVID-19 update: Covid-19-associated coagulopathy.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
[No Abstract] [Full Text] [Related]
11. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
[TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19.
Salah HM; Mehta JL
Am J Cardiol; 2021 Mar; 142():158-159. PubMed ID: 33417877
[No Abstract] [Full Text] [Related]
13. COVID-19-associated coagulopathy.
Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
[TBL] [Abstract][Full Text] [Related]
14. Apixaban in patients with atrial fibrillation.
Lynch DR
N Engl J Med; 2011 Jun; 364(24):2362-3; author reply 2363-4. PubMed ID: 21675902
[No Abstract] [Full Text] [Related]
15. Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation.
Man-Son-Hing M; Laupacis A
Arch Intern Med; 2002 Mar; 162(5):541-50. PubMed ID: 11871922
[TBL] [Abstract][Full Text] [Related]
16. Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?
Evans A; Perez I; Yu G; Kalra L
Stroke; 2001 Dec; 32(12):2828-32. PubMed ID: 11739981
[TBL] [Abstract][Full Text] [Related]
17. [Aspirin in the treatment and prevention of stroke].
Laguta PS; Panchenko EP
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 10):61-5. PubMed ID: 15565841
[No Abstract] [Full Text] [Related]
18. Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
An H; Zhang J; Zhou T; Li T; Li S; Huang C; Chen C; Ying B; Xu Z; Jin S; Li X; Li M
Clin Immunol; 2021 Nov; 232():108852. PubMed ID: 34520860
[TBL] [Abstract][Full Text] [Related]
19. Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device.
Hodges K; Mubashir M; Insler J; Estep J; Hsich E; Tong M; Insler S; Soltesz E
J Card Surg; 2020 Nov; 35(11):3202-3204. PubMed ID: 32789890
[TBL] [Abstract][Full Text] [Related]
20. Potential mechanisms of cerebrovascular diseases in COVID-19 patients.
Lou M; Yuan D; Liao S; Tong L; Li J
J Neurovirol; 2021 Feb; 27(1):35-51. PubMed ID: 33534131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
